TY - JOUR
T1 - Alzheimer’s disease pathogenetic progression is associated with changes in regulated retained introns and editing of circular RNAs
AU - Arizaca Maquera, Karol Andrea
AU - Welden, Justin Ralph
AU - Margvelani, Giorgi
AU - Miranda Sardón, Sandra C.
AU - Hart, Samantha
AU - Robil, Noémie
AU - Hernandez, Alvaro Gonzalo
AU - de la Grange, Pierre
AU - Nelson, Peter T.
AU - Stamm, Stefan
N1 - Publisher Copyright:
Copyright © 2023 Arizaca Maquera, Welden, Margvelani, Miranda Sardón, Hart, Robil, Hernandez, de la Grange, Nelson and Stamm.
PY - 2023
Y1 - 2023
N2 - Introduction: The molecular changes leading to Alzheimer’s disease (AD) progression are poorly understood. A decisive factor in the disease occurs when neurofibrillary tangles (NFT) composed of microtubule associated protein tau (MAPT) form in the entorhinal cortex and then spread throughout the brain. Methods: We therefore determined mRNA and circular RNA changes during AD progression, comparing Braak NFT stages I-VI. Total RNA was isolated from human brain (entorhinal and frontotemporal cortex). Poly(A)+ RNA was subjected to Nanopore sequencing, and total RNA was analyzed by standard Illumina sequencing. Circular RNAs were sequenced from RNase R treated and rRNA depleted total RNA. The sequences were analyzed using different bioinformatic tools, and expression constructs for circRNAs were analyzed in transfection experiments. Results: We detected 11,873 circRNAs of which 276 correlated with Braak NFT stages. Adenosine to inosine RNA editing increased about threefold in circRNAs during AD progression. Importantly, this correlation cannot be detected with mRNAs. CircMAN2A1 expression correlated with AD progression and transfection experiments indicated that RNA editing promoted its translation using start codons out of frame with linear mRNAs, which generates novel proteins. Discussion: Thus, we identified novel regulated retained introns that correlate with NFT Braak stages and provide evidence for a role of translated circRNAs in AD development.
AB - Introduction: The molecular changes leading to Alzheimer’s disease (AD) progression are poorly understood. A decisive factor in the disease occurs when neurofibrillary tangles (NFT) composed of microtubule associated protein tau (MAPT) form in the entorhinal cortex and then spread throughout the brain. Methods: We therefore determined mRNA and circular RNA changes during AD progression, comparing Braak NFT stages I-VI. Total RNA was isolated from human brain (entorhinal and frontotemporal cortex). Poly(A)+ RNA was subjected to Nanopore sequencing, and total RNA was analyzed by standard Illumina sequencing. Circular RNAs were sequenced from RNase R treated and rRNA depleted total RNA. The sequences were analyzed using different bioinformatic tools, and expression constructs for circRNAs were analyzed in transfection experiments. Results: We detected 11,873 circRNAs of which 276 correlated with Braak NFT stages. Adenosine to inosine RNA editing increased about threefold in circRNAs during AD progression. Importantly, this correlation cannot be detected with mRNAs. CircMAN2A1 expression correlated with AD progression and transfection experiments indicated that RNA editing promoted its translation using start codons out of frame with linear mRNAs, which generates novel proteins. Discussion: Thus, we identified novel regulated retained introns that correlate with NFT Braak stages and provide evidence for a role of translated circRNAs in AD development.
KW - Alzheimer
KW - Braak stage
KW - alternative splicing
KW - circular RNAs
KW - gene expression
KW - retained intron
UR - http://www.scopus.com/inward/record.url?scp=85161000456&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85161000456&partnerID=8YFLogxK
U2 - 10.3389/fnmol.2023.1141079
DO - 10.3389/fnmol.2023.1141079
M3 - Article
C2 - 37266374
AN - SCOPUS:85161000456
SN - 1662-5099
VL - 16
JO - Frontiers in Molecular Neuroscience
JF - Frontiers in Molecular Neuroscience
M1 - 1141079
ER -